Our body may cure itself of diabetes in future: Study

Image
Press Trust of India London
Last Updated : Jan 07 2019 | 2:55 PM IST

Researchers have identified cells in the human body that can take over functions of damaged or missing insulin-producing cells, an advance that may lead to new treatments for diabetes.

Diabetes is caused by damaged or non-existing insulin cells' inability to produce insulin, a hormone that is necessary in regulating blood sugar levels.

Many diabetes patients take insulin supplements to regulate these levels, said researchers from the University of Bergen in Norway.

They discovered that glucagon producing cells in the pancreas can change identity and adapt so that they do the job for their neighbouring damaged or missing insulin cells.

"We are possibly facing the start of a totally new form of treatment for diabetes, where the body can produce its own insulin, with some start-up help," said Luiza Ghila from the University of Bergen.

The researchers discovered that only about two per cent of the neighbouring cells in the pancreas could change identity.

However, even that amount makes the researchers optimistic about potential new treatment approaches.

Researchers were able to describe the mechanisms behind the process of cell identity.

It turns out that this is not at passive process, but is a result of signals from the surrounding cells.

In the study, researchers were able to increase the number of insulin producing cells to five per cent, by using a drug that influenced the inter-cell signalling process.

Thus far, the results have only been shown in animal models, researchers said.

"If we gain more knowledge about the mechanisms behind this cell flexibility, then we could possibly be able to control the process and change more cells' identities so that more insulin can be produced," Ghila said.

According to the researchers, the new discoveries is not only good news for diabetes treatment.

"The cells' ability to change identity and function, may be a decisive discovery in treating other diseases caused by cell death, such as Alzheimer's disease and cellular damage due to heart attacks," said Ghila.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 07 2019 | 2:55 PM IST

Next Story